A nationwide vaccine perception survey conducted by the National Vaccine Institute has revealed that a strong majority of Ghanaians continue to trust vaccines and are prepared to support Ghana’s ambitious local vaccine manufacturing agenda expected to commence in 2027.
The findings, released in Accra yesterday under the authority of the Chief Executive Officer of the NVI, Dr. Sodzi Sodzi-Tettey, challenge the long-held assumption that vaccine hesitancy is widespread in Ghana following the COVID-19 pandemic.
According to the survey, about 89.7 percent of respondents expressed confidence in vaccines, while 94.2 percent indicated that ensuring vaccine availability was a collective national responsibility. Significantly, 71.3 percent said they would willingly accept vaccines manufactured in Ghana once local production begins.
The study, described as one of the most comprehensive national assessments of vaccine attitudes in Ghana, analysed 13,905 valid responses collected across all 16 regions and 55 districts.
The research examined public confidence in vaccines, misinformation trends, barriers to acceptance of locally produced vaccines and the broader social psychology surrounding vaccine uptake in Ghana.
The findings come at a critical time as Ghana intensifies efforts to establish domestic vaccine production capacity as part of a broader pharmaceutical industrialisation and health security strategy.
Trust In Science And Health Institutions
One of the strongest findings of the survey was the exceptionally high level of public trust in healthcare professionals and national regulatory institutions.
According to the report, 87.8 percent of respondents expressed confidence in doctors and nurses administering vaccines, while many also indicated trust in the Ghana Health Service and the Food and Drugs Authority.
Public health experts say this institutional trust could become one of Ghana’s most strategic assets as the country transitions from vaccine import dependence toward local biopharmaceutical manufacturing.
The survey suggests that healthcare workers may become central actors in combating misinformation and promoting acceptance of locally manufactured vaccines.
Awareness Gap Raises Concern
Despite the strong confidence in vaccines, the survey exposed what the NVI described as a “critical awareness deficit” regarding Ghana’s vaccine manufacturing plans.
Only 14.3 percent of respondents were aware that Ghana is preparing to manufacture vaccines locally ahead of the planned 2027 rollout.
The findings suggest that although public confidence in vaccination science remains high, awareness of the industrial and scientific infrastructure behind Ghana’s vaccine self-sufficiency agenda remains limited.
This gap, according to analysts, could create vulnerabilities for misinformation campaigns if public education efforts fail to keep pace with the country’s pharmaceutical transition.
The survey also uncovered notable geographical differences in vaccine acceptance.
Urbanised regions such as Greater Accra Region, Ashanti Region and Central Region recorded comparatively lower vaccine acceptance levels despite higher exposure to information and digital media.
In contrast, rural communities in northern Ghana and the Oti Region demonstrated stronger trust and acceptance of vaccines.
Health communication researchers have increasingly linked such patterns globally to the influence of online misinformation ecosystems, political distrust and social media-driven conspiracy narratives often concentrated in urban settings.
Cold Chain Concerns And Cost Barriers
While respondents expressed pride in the prospect of Ghana-made vaccines, the survey identified operational concerns that could affect uptake.
Key concerns included vaccine cost, long travel distances to vaccination centres and fears surrounding vaccine storage and transportation systems.
The report specifically highlighted weaknesses in cold chain systems — the temperature-controlled infrastructure required to safely transport and store vaccines — particularly in rural communities.
Public health experts warn that even scientifically effective vaccines can lose potency when exposed to temperature instability, making cold chain reliability a critical component of national immunisation systems.
The NVI said the findings reinforce the need to strengthen vaccine logistics infrastructure, storage systems and transparent handling protocols in order to maintain public confidence.
National Campaign Planned Ahead Of 2027 Rollout
In response to the findings, the NVI announced plans to launch a nationwide vaccine awareness and acceptance campaign aimed at educating the public on locally manufactured vaccines and countering misinformation.
The campaign is expected to involve government agencies, healthcare professionals, civil society groups, development partners, traditional leaders, the private sector and the media.
According to Dr. Sodzi-Tettey, Ghana possesses a “strong foundation of vaccine confidence,” but success would depend on closing the awareness gap surrounding locally manufactured vaccines.
He stressed the need for targeted policy interventions, strategic science communication and measures to address regional disparities and misinformation.
The NVI boss also acknowledged the support of the World Health Organization, GHS and FDA in advancing Ghana’s vaccine preparedness agenda.
Strategic Shift Toward Vaccine Sovereignty
The survey findings carry broader implications beyond public health.
Ghana’s vaccine manufacturing agenda forms part of a continental push under the Partnerships for African Vaccine Manufacturing initiative, which seeks to ensure that Africa locally produces at least 60 percent of its vaccines by 2040.
The initiative gained urgency following the COVID-19 pandemic, during which African countries struggled to secure timely access to vaccines amid global supply chain inequalities.
Analysts say Ghana’s planned entry into vaccine manufacturing could position the country as a regional biotechnology and pharmaceutical hub while strengthening national resilience against future pandemics and emerging infectious diseases.
For Ghana, the transition represents not only a public health intervention, but also a scientific, industrial and geopolitical milestone tied to economic resilience, pharmaceutical innovation and national sovereignty.
The survey concludes that with sustained public education, institutional transparency and strong stakeholder collaboration, Ghana could emerge as one of Africa’s leading examples of vaccine confidence and local pharmaceutical innovation.
For more news, join The Chronicle Newspaper channel on WhatsApp: https://whatsapp.com/channel/0029VbBSs55E50UqNPvSOm2z
